These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Cryptosporidiosis: prevalence and water-related outbreaks of infection]. Turbabina NA Med Parazitol (Mosk); 2012; (3):55-8. PubMed ID: 23088154 [TBL] [Abstract][Full Text] [Related]
9. [Highly Active AntiRetroviral Therapy and cryptosporidiosis]. Morales Gomez MA Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695 [TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of human cryptosporidiosis. Farthing MJ Contrib Microbiol; 2000; 6():50-74. PubMed ID: 10943507 [No Abstract] [Full Text] [Related]
11. Widespread occurrence of Cryptosporidium infections in patients with HIV/AIDS: Epidemiology, clinical feature, diagnosis, and therapy. Wang RJ; Li JQ; Chen YC; Zhang LX; Xiao LH Acta Trop; 2018 Nov; 187():257-263. PubMed ID: 30118699 [TBL] [Abstract][Full Text] [Related]
12. [Cryptosporidium infection in patients with major histocompatibility complex class II deficiency syndrome in Tunisia: description of five cases]. Ben Abda I; Essid R; Mellouli F; Aoun K; Bejaoui M; Bouratbine A Arch Pediatr; 2011 Sep; 18(9):939-44. PubMed ID: 21816586 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice. Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052 [TBL] [Abstract][Full Text] [Related]
14. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice. Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481 [TBL] [Abstract][Full Text] [Related]
15. Prevalence, molecular characteristics and risk factors for cryptosporidiosis among Iranian immunocompromised patients. Izadi M; Jonaidi-Jafari N; Saburi A; Eyni H; Rezaiemanesh MR; Ranjbar R Microbiol Immunol; 2012 Dec; 56(12):836-42. PubMed ID: 23088420 [TBL] [Abstract][Full Text] [Related]
16. [Intestinal cryptosporidiosis in HIV infected children]. Barboni G; Candi M; Inés Villacé M; Leonardelli A; Balbaryski J; Gaddi E Medicina (B Aires); 2008; 68(3):213-8. PubMed ID: 18689152 [TBL] [Abstract][Full Text] [Related]
17. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Carr A; Marriott D; Field A; Vasak E; Cooper DA Lancet; 1998 Jan; 351(9098):256-61. PubMed ID: 9457096 [TBL] [Abstract][Full Text] [Related]
18. Infectivity of preserved Cryptosporidium parvum oocysts for immunosuppressed adult mice. Yang S; Healey MC; Du C FEMS Immunol Med Microbiol; 1996 Feb; 13(2):141-5. PubMed ID: 8731022 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Hunter PR; Nichols G Clin Microbiol Rev; 2002 Jan; 15(1):145-54. PubMed ID: 11781272 [TBL] [Abstract][Full Text] [Related]
20. [Human cryptosporidiosis and Cryptosporidium spp. in Haiti]. Raccurt CP; Brasseur P; Verdier RI; Li X; Eyma E; Stockman CP; Agnamey P; Guyot K; Totet A; Liautaud B; Nevez G; Dei-Cas E; Pape JW Trop Med Int Health; 2006 Jun; 11(6):929-34. PubMed ID: 16772015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]